Uncategorized
Ozurdex Reduced DME in Vitrectomized Eyes
The Ozurdex dexamethasone intravitreal implant
(Allergan, Inc.) effectively reduced DME and improved
visual acuity in vitrectomized eyes, according to data presented
by Leonard Feiner, MD, at the ASRS meeting.1
In a 6-month, prospective, multicenter, open-label
study, 56 patients with DME and a history of pars plana
v...